Insider Transactions in Q1 2022 at Renaissancere Holdings LTD (RNR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Anthony M Santomero Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+4.94%
|
-
|
|
Mar 01
2022
|
James L Gibbons Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,096
+7.15%
|
-
|
|
Mar 01
2022
|
Jean D Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+3.84%
|
-
|
|
Mar 01
2022
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+5.13%
|
-
|
|
Mar 01
2022
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+4.94%
|
-
|
|
Mar 01
2022
|
Carol P Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+12.97%
|
-
|
|
Mar 01
2022
|
Duncan P Hennes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+15.23%
|
-
|
|
Mar 01
2022
|
Cynthia Trudell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+22.05%
|
-
|
|
Mar 01
2022
|
Brian Gerald John Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+6.2%
|
-
|
|
Mar 01
2022
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,162
-0.79%
|
$313,490
$145.49 P/Share
|
|
Mar 01
2022
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,752
+11.29%
|
-
|
|
Mar 01
2022
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,196
+13.82%
|
-
|
|
Mar 01
2022
|
Shannon Lowry Bender EVP, General Counsel & Secty |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-4.37%
|
$26,390
$145.49 P/Share
|
|
Mar 01
2022
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
2,199
+34.55%
|
-
|
|
Mar 01
2022
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+19.09%
|
-
|
|
Mar 01
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,647
-0.92%
|
$383,815
$145.49 P/Share
|
|
Mar 01
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,184
+11.0%
|
-
|
|
Mar 01
2022
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,684
+6.13%
|
-
|
|
Mar 01
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,781
-0.42%
|
$838,245
$145.49 P/Share
|
|
Mar 01
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,702
+8.85%
|
-
|
|
Mar 01
2022
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,065
+15.23%
|
-
|
|
Feb 04
2022
|
Ross Curtis EVP,Chief Portfolio Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,426
-1.86%
|
-
|
|
Feb 04
2022
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,666
-4.52%
|
-
|
|
Feb 04
2022
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,091
-3.59%
|
-
|
|
Feb 04
2022
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,282
-4.14%
|
-
|